Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Patients Treated With Mastectomy: Indications for Treatment and Oncological Outcomes
Residual DCIS after NAC did not significantly impact DFS or OS compared to complete pathologic response without residual DCIS. This study underscores the need for further research to refine pCR definitions and improve NAC's prognostic and therapeutic roles in BC management.
Authors
- Andrea Sagona (ORCID: https://orcid.org/0000-0002-4372-9921)
- Shadya Sara Darwish (ORCID: https://orcid.org/0000-0002-8742-0942)
- E. Barbieri (ORCID: https://orcid.org/0000-0002-4980-3985)
- Valeriano Vinci (ORCID: https://orcid.org/0000-0001-5234-6044)
- Damiano Gentile (ORCID: https://orcid.org/0000-0002-8861-5223)
- Corrado Tinterri (ORCID: https://orcid.org/0000-0002-7272-3924)
Institutions
- Humanitas University (IT)
- Humanitas Gavazzeni (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- European Journal of Breast Health
- Published
- 2024-09-26
- DOI
- https://doi.org/10.4274/ejbh.galenos.2024.2024-6-3
- Citations
- 4
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.14